Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

Liotta, L. A., Steeg, P. S., & Stetler‐Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,701 · see citing works

Plasminogen Activators, Tissue Degradation, and Cancer

Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen, P., Nielsen, L. S., & Skriver, L. (1985) · Advances in cancer research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535 · see citing works

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

Ducharme, A., Frantz, S., Aikawa, M., Aikawa, E. R., Lindsey, M. L., Rohde, L. E. P., Schöen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808 · see citing works

Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade

Mignatti, P., Robbins, E. S., & Rifkin, D. B. (1986) · Cell · doi:10.1016/0092-8674(86)90613-6 · Cited by 741 · see citing works

Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

Beltrami, C. A., Finato, N., Rocco, M., Feruglio, G. A., Puricelli, C., Cigola, E., Quaini, F., Sonnenblick, E. H., Olivetti, G., & Anversa, P. (1994) · Circulation · doi:10.1161/01.cir.89.1.151 · Cited by 595 · see citing works

Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat.

Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E., & Reidy, M. A. (1994) · Circulation Research · doi:10.1161/01.res.75.3.539 · Cited by 584 · see citing works

Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated Cardiomyopathy

Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.97.17.1708 · Cited by 443 · see citing works

Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart

Li, Y. Y., Feldman, A. M., Sun, Y., & McTiernan, C. F. (1998) · Circulation · doi:10.1161/01.cir.98.17.1728 · Cited by 372 · see citing works

Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart Failure

Spinale, F. G., Coker, M. L., Thomas, C. V., Walker, J. D., Mukherjee, R. D., & Hebbar, L. (1998) · Circulation Research · doi:10.1161/01.res.82.4.482 · Cited by 372 · see citing works

Proteinases and extracellular remodeling

Alexander, C. M., & Werb, Z. (1989) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(89)90068-9 · Cited by 225 · see citing works

Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells

Cho, A., Graves, J. D., & Reidy, M. A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2527 · Cited by 199 · see citing works

Zymogen of tadpole collagenase

Harper, E., Bloch, K. J., & Gross, J. (1971) · Biochemistry · doi:10.1021/bi00792a008 · Cited by 193 · see citing works

Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1

Damiano, B. P., Cheung, W. M., Santulli, R. J., Fung‐Leung, W., Ngo, K., Ye, R. D., Darrow, A. L., Derian, C. K., de Garavilla, L., & Andrade‐Gordon, P. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38005-x · Cited by 182 · see citing works

The coagulation system is activated in idiopathic cardiomyopathy

Yamamoto, K., Ikeda, U., Furuhashi, K., Irokawa, M., Nakayama, T., & Shimada, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00049-a · Cited by 170 · see citing works

Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus

Tyagi, S. C., Matsubara, L. S., & Weber, K. T. (1993) · Clinical Biochemistry · doi:10.1016/0009-9120(93)90025-2 · Cited by 170 · see citing works

Signaling Properties and Functions of Two Distinct Cardiomyocyte Protease-Activated Receptors

Sabri, A., Muske, G., Zhang, H., Pak, E. S., Darrow, A. L., Andrade‐Gordon, P., & Steinberg, S. F. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1054 · Cited by 166 · see citing works

Activation of Matrix Metalloproteinases in the Failing Human Heart

Mann, D. L., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.98.17.1699 · Cited by 164 · see citing works

Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.

Khokha, R., & Dt, D. (1989) · PubMed · Cited by 159 · see citing works

Contribution of ventricular remodeling to pathogenesis of heart failure in rats

Brower, G. L., & Janicki, J. S. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h674 · Cited by 158 · see citing works

Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts

Tyagi, S. C., Campbell, S. E., Reddy, H. K., Tjahja, E., & Welker, D. J. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00714328 · Cited by 154 · see citing works

Myocardial matrix metalloproteinase(s): localization and activation

Tyagi, S. C., Ratajska, A., & Weber, K. T. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf01772207 · Cited by 141 · see citing works

Post-transcriptional Regulation of Extracellular Matrix Metalloproteinase in Human Heart End-stage Failure Secondary to Ischemic Cardiomyopathy

Tyagi, S. C. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0132 · Cited by 139 · see citing works

Myocardial matrix metalloproteinase activity and abundance with congestive heart failure

Coker, M. L., Thomas, C. V., Clair, M. J., Hendrick, J. W., Krombach, R. S., Galis, Z. S., & Spinale, F. G. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.5.h1516 · Cited by 128 · see citing works

Protease-Activated Receptor (PAR), a Novel Family of G Protein-Coupled Seven Trans-membrane Domain Receptors: Activation Mechanisms and Physiological Roles

Kawabata, A., & Kuroda, R. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.82.171 · Cited by 80 · see citing works

Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart‐derived fibroblast and endomyocardial endothelial cells

Tyagi, S. C., Suresh Kumar, G., & Glover, G. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580309 · Cited by 76 · see citing works

Real-Time Zymography and Reverse Zymography: A Method for Detecting Activities of Matrix Metalloproteinases and Their Inhibitors Using FITC-Labeled Collagen and Casein as Substrates

Hattori, S., Fujisaki, H., Kiriyama, T., Yokoyama, T., & Irie, S. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5479 · Cited by 68 · see citing works

Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure

Hunt, M. J., Aru, G. M., Hayden, M. R., Moore, C. K., Hoit, B. D., & Tyagi, S. C. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00001.2002 · Cited by 64 · see citing works

Attenuation of Oxidative Stress and Remodeling by Cardiac Inhibitor of Metalloproteinase Protein Transfer

Cox, M. J., Hawkins, U. A., Hoit, B. D., & Tyagi, S. C. (2004) · Circulation · doi:10.1161/01.cir.0000127429.53391.78 · Cited by 47 · see citing works

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure

Moshal, K. S., Tyagi, N., Henderson, B. C., Ovechkin, A. V., & Tyagi, S. C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01146.2004 · Cited by 40 · see citing works

A latent collagenase released by bone and skin explants in culture

Vaes, G. (1971) · Biochemical Journal · doi:10.1042/bj1230023pb · Cited by 28 · see citing works

Myocardial collagen matrix remodeling and congestive heart failure.

Cg, B., & Rupp, H. (1994) · PubMed · Cited by 27 · see citing works

Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus

Erbay, A. R., Turhan, H., Aksoy, Y., Şenen, K., & Yetkın, E. (2004) · Coronary Artery Disease · doi:10.1097/01.mca.0000135596.54871.6f · Cited by 20 · see citing works

Myocardial Interstitial Matrix Metalloproteinase Activity Is Altered by Mechanical Changes in LV Load

Deschamps, A. M., Apple, K. A., Leonardi, A. H., McLean, J. E., Yarbrough, W. M., Stroud, R. E., Clark, L. L., Sample, J. A., & Spinale, F. G. (2005) · Circulation Research · doi:10.1161/01.res.0000167830.12010.6b · Cited by 18 · see citing works

The coagulation system is activated in idiopathic cardiomyopathy.

Lip, G. (1995) · PubMed · Cited by 4 · see citing works

Cardiac remodeling in obesity

Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works

Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications

Lau, D. H., Schotten, U., Mahajan, R., Antic, N. A., Hatem, S. N., Pathak, R. K., Hendriks, J., Kalman, J. M., & Sanders, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv375 · Cited by 171 · see citing works

Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation

Spronk, H. M. H., de Jong, A. M., Verheule, S., de Boer, H. C., Maass, A. H., Lau, D. H., Rienstra, M., van Hunnik, A., Kuiper, M., Lumeij, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw119 · Cited by 170 · see citing works

Extracellular matrix-mediated cellular communication in the heart

Valiente-Alandí, Í., Schafer, A. E., & Blaxall, B. C. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.011 · Cited by 164 · see citing works

Decellularized matrices for cardiovascular tissue engineering.

Moroni, F., & Mirabella, T. (2014) · Europe PMC (PubMed Central) · Cited by 149 · see citing works

Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants

Spronk, H. M. H., de Jong, A. M., Crijns, H. J. G. M., Schotten, U., Gelder, I. C. V., & Cate, H. T. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvt343 · Cited by 145 · see citing works

Atrial extracellular matrix remodelling in patients with atrial fibrillation

Polyakova, V. O., Miyagawa, S., Szalay, Z., Risteli, J., & Sawa Kostin, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00219.x · Cited by 145 · see citing works

Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy

Pawliński, R., Tencati, M., Hampton, C. R., Shishido, T., Bullard, T. A., Casey, L. M., Andrade‐Gordon, P., Kotzsch, M., Spring, D. J., Luther, T., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.692764 · Cited by 143 · see citing works

Coagulation and coagulation signalling in fibrosis

Mercer, P. F., & Chambers, R. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.013 · Cited by 119 · see citing works

H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure

Mishra, P. K., Tyagi, N., Sen, U., Givvimani, S., & Tyagi, S. C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00682.2009 · Cited by 102 · see citing works

β-Adrenergic Receptor Stimulation Transactivates Protease-Activated Receptor 1 via Matrix Metalloproteinase 13 in Cardiac Cells

Jaffré, F., Friedman, A. E., Hu, Z., Mackman, N., & Blaxall, B. C. (2012) · Circulation · doi:10.1161/circulationaha.111.066787 · Cited by 91 · see citing works

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

Roldán, V., Marín, F. R., Gimeno, J. R., Espejo, F. R., González, J. M. R., Feliu, E., García‐Honrubia, A., Saura, D., de la Morena, G., Valdés, M., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.035 · Cited by 91 · see citing works

Dysregulation of Mfn2 and Drp-1 proteins in heart failure

Givvimani, S., Pushpakumar, S. B., Veeranki, S., & Tyagi, S. C. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0060 · Cited by 78 · see citing works

Protease-Activated Receptor 1 Inhibition by SCH79797 Attenuates Left Ventricular Remodeling and Profibrotic Activities of Cardiac Fibroblasts

Sonin, D. L., Wakatsuki, T., Routhu, K. V., Harmann, L. M., Petersen, M., Meyer, J., & Strande, J. L. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413485434 · Cited by 66 · see citing works

Cardiac matrix: A clue for future therapy

Mishra, P. K., Givvimani, S., Chavali, V., & Tyagi, S. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.004 · Cited by 59 · see citing works

Hydrogen sulfide protects against vascular remodeling from endothelial damage

Vacek, T. P., Gillespie, W., Tyagi, N., Vacek, J. C., & Tyagi, S. C. (2010) · Amino Acids · doi:10.1007/s00726-010-0550-2 · Cited by 58 · see citing works

Protease‐activated receptors and myocardial infarction

Antoniak, S., Pawliński, R., & Mackman, N. (2011) · IUBMB Life · doi:10.1002/iub.441 · Cited by 56 · see citing works

Role of mitochondrial fission and fusion in cardiomyocyte contractility

Givvimani, S., Pushpakumar, S. B., Metreveli, N. S., Veeranki, S., Kundu, S., & Tyagi, S. C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.352 · Cited by 51 · see citing works

Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: Inhibition by salvianolic acid B from Salvia miltiorrhiza

Wang, Y., Xu, F., Chen, J., Shen, X., Deng, Y., Xu, L., Yin, J., Chen, H., Teng, F., Liu, X., et al. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.06.024 · Cited by 48 · see citing works

Granzymes in cardiovascular injury and disease

Zeglinski, M. R., & Granville, D. J. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109804 · Cited by 50 · see citing works

Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen

Sangaralingham, S. J., Wang, B. H., Huang, L., Kumfu, S., Ichiki, T., Krum, H., & Burnett, J. C. J. (2016) · Peptides · doi:10.1016/j.peptides.2016.01.004 · Cited by 43 · see citing works

Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?

Vestri, A., Pierucci, F., Frati, A., Monaco, L., & Meacci, E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00296 · Cited by 44 · see citing works

Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice

Dong, A., Mueller, P., Yang, F., Yang, L., Morris, A. J., & Smyth, S. S. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.09.016 · Cited by 35 · see citing works

Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats

Burlá, A. K., Lobato, N. S., Fortes, Z. B., Oigman, W., & Neves, M. F. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.012 · Cited by 34 · see citing works

Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure

Miyagawa, S., Toda, K., Nakamura, T., Yoshikawa, Y., Fukushima, S., Saito, S., Yoshioka, D., Saito, T., & Sawa, Y. (2015) · Surgery Today · doi:10.1007/s00595-015-1149-8 · Cited by 34 · see citing works

Atorvastatin Slows the Progression of Cardiac Remodeling in Mice with Pressure Overload and Inhibits Epidermal Growth Factor Receptor Activation

Liao, Y., Zhao, H., Ogai, A., Kato, H., Asakura, M., Kim, J., Asanuma, H., Minamino, T., Takashima, S., & Kitakaze, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.335 · Cited by 31 · see citing works

Renal mitochondrial damage and protein modification in type-2 diabetes

Kartha, G., Moshal, K. S., Sen, U., Joshua, I. G., Tyagi, N., Steed, M. M., & Tyagi, S. C. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0025-z · Cited by 31 · see citing works

ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells

Cheng, Y., Kuo, W., Wu, H., Lai, T.-Y., Wu, C., Hwang, J.-M., Wang, W.-H., Tsai, F., Yang, J., Huang, C., et al. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-0021-1 · Cited by 28 · see citing works

Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review

Herrmann, W., Herrmann, M., Joseph, J., & Tyagi, S. C. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.360 · Cited by 27 · see citing works

GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice

Kumar, M., Tyagi, N., Moshal, K. S., Sen, U., Pushpakumar, S. B., Vacek, T. P., Lominadze, D. G., & Tyagi, S. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.021 · Cited by 25 · see citing works

Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure.

Tyagi, N., Mishra, P. K., & Tyagi, S. C. (2009) · PubMed · Cited by 24 · see citing works

Involvement of Protein Kinase C and RhoA in Protease-Activated Receptor 1–Mediated F-Actin Reorganization and Cell Growth in Rat Cardiomyocytes

Otani, H., Yoshioka, K., Nishikawa, H., Inagaki, C., & Nakamura, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10197fp · Cited by 23 · see citing works

PAR 1‐dependent COX ‐2/ PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes

Chien, P. T., Hsieh, H., Chi, P., & Yang, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12794 · Cited by 21 · see citing works

Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aortaThis article is one of a selection of papers published in a special issue on Advances in Cardiovascular Research.

Zeydanli, E. N., & Turan, B. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-112 · Cited by 17 · see citing works

Molecular Mechanisms of Atrial Fibrillation Recurrence After Successful Catheter Ablation

Sanusi, M., Vempati, R., Umashankar, D., Tarannum, S., Varma, Y. K., Mohammed, F., Mylavarapu, M., Zakaria, F., Nair, R. C., Reddy, Y. M., et al. (2025) · Cells · doi:10.3390/cells15010036 · Cited by 15 · see citing works

Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia

Moshal, K. S., Camel, C., Kartha, G., Steed, M. M., Tyagi, N., Sen, U., Kang, Y. J., Lominadze, D. G., Maldonado, C. J., & Tyagi, S. C. (2007) · Current Neurovascular Research · doi:10.2174/156720207782446324 · Cited by 12 · see citing works

Clonal hematopoiesis is associated with cardiovascular events in patients with stable coronary artery disease

Dregoesc, M. I., Tercan, H., Țigu, A. B., Bekkering, S., Joosten, L. A. B., Netea, M. G., van Deuren, R. C., Hoischen, A., Riksen, N. P., & Iancu, A. C. (2024) · iScience · doi:10.1016/j.isci.2024.109472 · Cited by 10 · see citing works

Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01378-9 · Cited by 9 · see citing works

Hyperbaric oxygen therapy mitigates left ventricular remodeling, upregulates MMP-2 and VEGF, and inhibits the induction of MMP-9, TGF-β1, and TNF-α in streptozotocin-induced diabetic rat heart

Silva, F. S., de Souza, K. S. C., Galdino, O. A., de Moraes, M. V., Ishikawa, U., Medeiros, M. A., Lima, J. P. M. S., Medeiros, K. C. D. P., Farias, N. B. D. S., Júnior, R. F. D. A., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120393 · Cited by 9 · see citing works

The C-allele of tissue inhibitor of metalloproteinases 2 is associated with increased magnitude of QT dispersion prolongation in elderly Chinese — 4-year follow-up study

Lin, T., Chiu, H., Lee, Y.-T., Su, H., Juo, S. H., Voon, W., Lai, W., & Sheu, S. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.08.004 · Cited by 9 · see citing works

Recent Advances in Pharmacotherapy for Heart Failure: Future Directions

Balakumar, P., & Singh, M. (2007) · Trends in Medical Research · doi:10.3923/tmr.2007.61.71 · Cited by 9 · see citing works

Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors

Ise, T., Aihara, K., Sumitomo-Ueda, Y., Yoshida, S., Ikeda, Y., Yagi, S., Iwase, T., Yamada, H., Akaike, M., Sata, M., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.211 · Cited by 8 · see citing works

Effects of thrombin and thrombin receptor activation on cardiac function after acute myocardial infarction.

Gu, X., Zhang, X., Lu, G., Li, Y., Li, X., Huang, H., Zeng, J., & Tang, L. (2015) · PubMed Central · Cited by 5 · see citing works

Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

Yurista, S. R., Silljé, H. H. W., Nijholt, K. T., Dokter, M. M., van Veldhuisen, D. J., de Boer, R. A., & Westenbrink, B. D. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06999-7 · Cited by 5 · see citing works

Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice

Fletcher, E. K., Ngwenyama, N., Nguyen, N., Turner, S. E., Covic, L., Alcaide, P., & Kuliopulos, A. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010621 · Cited by 4 · see citing works

Targeting coagulation in heart failure with preserved ejection fraction and cardiac fibrosis

Hofmann, C., Völkers, M., & Katus, H. A. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz450 · Cited by 4 · see citing works

Potential Contribution of Pleiotropic Effects of Direct Anticoagulants to Clinical Benefits

Schneider, D. J. (2013) · Drug Development Research · doi:10.1002/ddr.21104 · Cited by 3 · see citing works

Recent Clinical and Experimental Advances in Atrial Fibrillation

Miyagawa, S., Sakaguchi, T., Nishi, H., Yoshikawa, Y., Fukushima, S., Saito, S., & Sawa, Y. (2011) · ISRN Cardiology · doi:10.5402/2011/958189 · Cited by 3 · see citing works

Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes

Fender, A. C., Pavic, G., Drummond, G. R., Dusting, G. J., & Ritchie, R. H. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1026-9 · Cited by 3 · see citing works

Inhibition of ADAMTS1 and ATP citrate lyase attenuates connexin-43 degradation and HFrEF

Zheng, Y.-T., & Tyagi, S. C. (2026) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0162 · Cited by 2 · see citing works

Review Article Decellularized matrices for cardiovascular tissue engineering

Moroni, F., & Mirabella, T. (2014) · Cited by 2 · see citing works

Novel Drug Targets in Diastolic Heart Disease

Er, T., Martinac, B., & Hool, L. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168055 · Cited by 1 · see citing works

EMERGING DRUG THERAPIES FOR HEART FAILURE

Balakumar, P., & Singh, M. (2006) · Iranian journal of pharmacology & therapeutics

Role of inducible nitric oxide synthase and p-selectin in platelet-arteriolar wall adhesion and associated arteriolar constriction during lung reperfusion.

Ovechkin, A. V. (2005) · doi:10.18297/etd/1087

Obesity and Cardiac Dysfunction

Sweeney, G., Litwin, S. E., & Abel, E. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_14

OBSOLETE: Vascular Repair at the Interface of the Endothelium: The Roles of Protease-Activated Receptors and Neuregulin-1

Cleator, J. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99584-9

Mitochondrial Transcription Factor A's role in heart failure.

Kunkel, G. H. (2017) · doi:10.18297/etd/2777

Vascular Repair at the Interface of the Endothelium: The Roles of Protease-Activated Receptors and Neuregulin-1

Galindo, C. L., Odiete, O., & Cleator, J. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99584-x

Additional file 7 of Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177513

Additional file 6 of Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177504

Additional file 8 of Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177519

Additional file 3 of Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177498

Additional file 2 of Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177489

Additional file 1 of Role of the ADCY9 gene in cardiac abnormalities of the Rubinstein-Taybi syndrome

Wu, Y., Xia, Y., Li, P., Qu, H., Liu, Y., Yang, Y., Lin, J., Zheng, M., Tian, L., Wu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12177483

Cardiac Gαs and Gαi Modulate Sympathetic Versus Parasympathetic Mechanisms in Hyperhomocysteinemia

Vacek, T. P., Moshal, K. S., Metreveli, N. S., Tyagi, N., Sen, U., Rosenberger, D., & Tyagi, S. C. (2008) · Springer eBooks · doi:10.1007/978-0-387-09552-3_3

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

Spinale, F. G., Coker, M. L., Heung, L. J., Bond, B. R., Gunasinghe, H. R., Etoh, T., Goldberg, A. T., Zellner, J. L., & Crumbley, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.16.1944 · Cited by 476 · see citing works

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

Spinale, F. G. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00431-9 · Cited by 211 · see citing works

Matrix Metalloproteinase 9 (MMP-9)

Zouein, F. A., DeCoux, A., Tian, Y., White, J. A., Jin, Y.-F., & Lindsey, M. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-17437-2_13 · Cited by 2 · see citing works

Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.

Kiczak, L., Tomaszek, A., Bania, J., Pasławska, U., Zacharski, M., Janiszewski, A., Rybińska, I., Dzięgiel, P., von Haehling, S., Ardehali, H., et al. (2014) · PubMed · Cited by 9 · see citing works

Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling

Li, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00003-1 · Cited by 434 · see citing works